William Stokes Jr

Department of Radiation Oncology
Assistant Professor

william.stokes@emoryhealthcare.org

Overview

William (Bill) Stokes, MD, is a radiation oncologist specializing in the treatment of head and neck cancer, and lung cancer in addition to stereotactic body radiotherapy. He treats patients at Emory University Hospital Midtown and Emory Proton Therapy Center.

Dr. Stokes graduated magna cum laude with a BS in Biology from Davidson College in Davidson, North Carolina. He received his medical degree from University of North Carolina School of Medicine in Chapel Hill, North Carolina. He then completed an internship in internal medicine and his residency in radiation oncology at University of Colorado School of Medicine in Denver, Colorado, where he was Chief Resident in his final year of residency training.

As a medical student, Dr. Stokes was selected as a Howard Holderness Distinguished Medical Scholar and completed a one-year research fellowship. During residency, he was selected by his peers for induction into the Gold Humanism Honor Society.

During his training, Dr. Stokes performed clinical research in using big data to investigate patterns of care and outcomes among cancer patients and developing phase I trials in head and neck cancer.

Dr. Stokes has published multiple manuscripts in oncology journals such as Cancer, International Journal of Radiation Oncology, Biology, Physics, and Journal of Clinical Oncology. He also serves as a reviewer for several journals, including Practical Radiation Oncology, Oral Oncology, Head and Neck, Radiotherapy and Oncology, and International Journal of Radiation Oncology, Biology, Physics.

Academic Appointment

Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

BS from Davidson College
MD from University of North Carolina at Chapel Hill

Research

Publications

The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Oncologist Volume: 30
02/06/2025 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
Institution-level Patterns of Care for Early-stage Oropharynx Cancers in the United States.
Am J Clin Oncol Volume: 47 Page(s): 542 - 548
11/01/2024 Authors: Janopaul-Naylor JR; Liu Y; Cao Y; Schlafstein AJ; Steuer C; Patel MR; Bates JE; McDonald MW; Stokes WA
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
Head Neck Volume: 46 Page(s): 2167 - 2177
09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nat Med Volume: 30 Page(s): 2373
08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
JAMA Oncol Volume: 10 Page(s): 896 - 904
07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M
Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC.
Int J Part Ther Volume: 12 Page(s): 100016
06/01/2024 Authors: Patel JS; McCall NS; Thomas M; Zhou J; Higgins KA; Bradley JD; Tian S; McDonald MW; Kesarwala AH; Stokes WA
Lung Cancer Survival Trends in the Veterans Health Administration.
Clin Lung Cancer Volume: 25 Page(s): 225 - 232
05/01/2024 Authors: Moghanaki D; Taylor J; Bryant AK; Vitzthum LK; Sebastian N; Gutman D; Burns A; Huang Z; Lewis JA; Spalluto LB
The Case for Allowing Proton Beam Therapy on Head and Neck Cooperative Group Studies.
JAMA Oncol Volume: 10 Page(s): 289 - 290
03/01/2024 Authors: McCall NS; Frank SJ; Stokes WA
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Lancet Oncol Volume: 25 Page(s): 366 - 375
03/01/2024 Authors: Gharzai LA; Morris E; Suresh K; Nguyen-Tn PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ
Initial experience and patient tolerance of proton stereotactic body radiotherapy.
J Radiosurg SBRT Volume: 9 Page(s): 121 - 128
01/01/2024 Authors: Ali N; Zhou J; Eaton BR; Switchenko JM; Cao Y; Stokes WA; Patel PR; Langen KM; Slopsema R; Bradley JD
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer.
Cancer Volume: 129 Page(s): 3713 - 3723
12/01/2023 Authors: McCall NS; Janopaul-Naylor JR; McGinnis HS; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal TA
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol Volume: 9 Page(s): 1565 - 1573
11/01/2023 Authors: Wong SJ; Torres-Saavedra PA; Saba NF; Shenouda G; Bumpous JM; Wallace RE; Chung CH; El-Naggar AK; Gwede CK; Burtness B
The expanding role of IAP antagonists for the treatment of head and neck cancer.
Cancer Med Volume: 12 Page(s): 13958 - 13965
07/01/2023 Authors: Kansal V; Kinney BLC; Uppada S; Saba NF; Stokes WA; Buchwald ZS; Schmitt NC
Insurance Authorization and Access to Proton Therapy for Patients With Head and Neck Cancers.
Int J Radiat Oncol Biol Phys Volume: 116 Page(s): 404 - 412
06/01/2023 Authors: McDonald MW; Bates JE; McCall NS; Goyal S; Liu Y; Rudra S; Remick JS; Tian S; El-Deiry MW; Saba NF
The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Clin Lung Cancer Volume: 24 Page(s): 287 - 294
05/01/2023 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nat Med Volume: 29 Page(s): 880 - 887
04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood.
Int J Radiat Oncol Biol Phys Volume: 115 Page(s): 1217 - 1228
04/01/2023 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.
Head Neck Volume: 45 Page(s): 664 - 674
03/01/2023 Authors: McDermott JD; Amini A; Molina E; Stokes WA; Karam SD
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities.
Head Neck Volume: 45 Page(s): 658 - 663
03/01/2023 Authors: Janopaul-Naylor JR; Rupji M; Tobillo RA; Lorenz JW; Switchenko JM; Tian S; Kaka AS; Qian DC; Schlafstein AJ; Steuer CE
Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
Lung Cancer Volume: 175 Page(s): 57 - 59
01/01/2023 Authors: Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck.
Front Oncol Volume: 13 Page(s): 1310106
01/01/2023 Authors: Puttagunta P; Pamulapati SV; Bates JE; Gross JH; Stokes WA; Schmitt NC; Steuer C; Teng Y; Saba NF
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.
Cancer Med Volume: 12 Page(s): 358 - 367
01/01/2023 Authors: Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sebastian NT; Sukhatme V; Lowe MC; Ramalingam SS
The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
Head Neck Volume: 44 Page(s): 2854 - 2864
12/01/2022 Authors: Schlafstein AJ; Goyal S; Amini A; Karam SD; Saba NF; Kaka AS; Aiken AH; Beitler JJ; Stokes WA
Current Radiotherapy Considerations for Nasopharyngeal Carcinoma.
Cancers (Basel) Volume: 14
11/24/2022 Authors: Ng WT; Chow JCH; Beitler JJ; Corry J; Mendenhall W; Lee AWM; Robbins KT; Nuyts S; Saba NF; Smee R
Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
Volume: 17 Page(s): S109 - S109
09/01/2022 Authors: Mccall NS; McGinnis HS; Janopaul-Naylor JR; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal T
Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Volume: 17 Page(s): S541 - S541
09/01/2022 Authors: Mccall NS; Switchenko JM; Tian S; Stokes WA; Kahn S; Kesarwala AH; Shelton JW; Szabo SM; Steuer CE; Carlisle JW
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era.
Radiother Oncol Volume: 174 Page(s): 133 - 140
09/01/2022 Authors: McCall NS; McGinnis HS; Janopaul-Naylor JR; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal T
Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.
Clin Lung Cancer Volume: 23 Page(s): e231 - e237
05/01/2022 Authors: Stokes WA; Xiong N; Liu Y; Higgins KA; Tian S; Bradley JD; Moghanaki D; Rusthoven CG
Patient-reported Outcomes in Oropharyngeal Cancer Treated With Definitive Chemoradiation vs. Surgery With Postoperative Radiation With or Without Chemotherapy
Volume: 113 Page(s): E2 - E2
05/01/2022 Authors: McDonald MW; Bates JE; Patel MR; Boyce BJ; Rudra S; Kaka AS; Steuer C; Shin DM; Tian S; Nathan MR
Predictors of Occult Nodal Involvement in Clinically Node Negative Primary Parotid Carcinoma: An NCDB Analysis
Volume: 112 Page(s): E16 - E17
04/01/2022 Authors: Lorenz J; Liu Y; Goyal S; Remick JS; Rudra S; Hanasoge S; Yu DS; Steuer C; Stokes WA
Institutional Comparison between Radiation with Concurrent Cisplatin Versus Carboplatin/paclitaxel for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Volume: 112 Page(s): E12 - E13
04/01/2022 Authors: Abousaud M; Shepherd M; Lozano F; Fowowe B; Cao Y; Rudra S; Stokes WA; Schmitt NC; El-Deiry MW; Patel MR
Factors Predictive of Primary Therapeutic Modality in Early-Stage Oropharyngeal Squamous Cell Carcinoma
Volume: 112 Page(s): E22 - E23
04/01/2022 Authors: Bates JE; Stokes WA; Remick JS; Rudra S; McDonald MW; Steuer C; Shin DM; Kaka AS; Saba NF; Patel MR
Adjuvant Oropharynx Cancer Management in the Era of Tors and HPV: A Recursive Partitioning Analysis
Volume: 112 Page(s): E15 - E15
04/01/2022 Authors: Janopaul-Naylor J; Rupji M; Lorenz J; Switchenko J; Bates JE; McDonald MW; Shin DM; Boyce BJ; Stokes WA
Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Chest Volume: 161 Page(s): 833 - 844
03/01/2022 Authors: Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S
Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
Oncologist Volume: 27 Page(s): 48 - 56
02/03/2022 Authors: Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C
Effect of Antibiotic Therapy on Immunotherapy Outcomes for Non-Small Cell Lung Cancer: Analysis From the Veterans Health Administration
Volume: 112 Page(s): E8 - E9
02/01/2022 Authors: Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sebastian N; Sukhatme VV; Lowe M; Ramalingam S
Accounting for Operability Status in Retrospective Comparisons of Surgery vs. SBRT for Early-Stage NSCLC
Volume: 112 Page(s): E11 - E11
02/01/2022 Authors: Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
Head Neck Volume: 44 Page(s): 382 - 390
02/01/2022 Authors: Dhere VR; Escott CE; Tian S; Switchenko JM; Bell JP; Stokes WA; McDonald MW; Magliocca KR; Boyce BJ; Kaka AS
To Scan or Not to Scan: The Dilemma of Posttreatment Imaging Surveillance of Head and Neck Cancer.
Pract Radiat Oncol Volume: 12 Page(s): 210 - 214
01/01/2022 Authors: Janopaul-Naylor JR; Aiken AH; Saba NF; El-Deiry M; Kaka AS; Stokes WA
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.
Front Oncol Volume: 12 Page(s): 1074675
01/01/2022 Authors: Janopaul-Naylor JR; Cao Y; McCall NS; Switchenko JM; Tian S; Chen H; Stokes WA; Kesarwala AH; McDonald MW; Shelton JW
Rapid Comparative Planning to Predict Oropharyngeal Toxicity Reduction for Proton Therapy vs. VMAT.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e396 - e397
11/01/2021 Authors: McDonald MW; Stokes WA; Tian S; Dhere VR; Xu KM; Pfister NT; Remick JS; Rudra S; Bates JE; Langen KM
Feasibility and Patient Tolerance of Proton Based Stereotactic Body Radiotherapy.
Volume: 111 Page(s): e473
11/01/2021 Authors: Ali N; Eaton BR; Zhou J; Stokes WA; Patel PR; Langen KM; Slopsema R; Bradley JD; McDonald MW
Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
Volume: 111 Page(s): E366 - E366
11/01/2021 Authors: Schlafstein A; Goyal S; Amini A; Karam SD; Saba NF; Kaka AS; Aiken AH; Beitler JJ; Stokes WA
Rapid Comparative Planning to Predict Oropharyngeal Toxicity Reduction for Proton Therapy vs. VMAT
Volume: 111 Page(s): E396 - E397
11/01/2021 Authors: McDonald MW; Stokes WA; Tian S; Dhere VR; Xu KM; Pfister NT; Remick JS; Rudra S; Bates JE; Langen KM
Feasibility and Patient Tolerance of Proton Based Stereotactic Body Radiotherapy
Volume: 111 Page(s): E473 - E473
11/01/2021 Authors: Ali N; Eaton BR; Zhou J; Stokes WA; Patel PR; Langen KM; Slopsema R; Bradley JD; McDonald MW
CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results
Volume: 111 Page(s): E361 - E361
11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e361
11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
Head Neck Volume: 43 Page(s): 3255 - 3275
11/01/2021 Authors: Stokes WA; Molina E; McDermott JD; Morgan RL; Bickett T; Fakhoury KR; Amini A; Karam SD
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S143 - S144
11/01/2021 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e366
11/01/2021 Authors: Schlafstein A; Goyal S; Amini A; Karam SD; Saba NF; Kaka AS; Aiken AH; Beitler JJ; Stokes WA
Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
Head Neck Volume: 43 Page(s): 3393 - 3403
11/01/2021 Authors: Amini A; Morgan R; Meyer E; Fakhoury K; Ladbury C; Bickett T; McDermott JD; Stokes W; Karam SD
More TORS, More Problems? Institution-level Patterns of Care for Early Stage Oropharynx Cancers in the US
Volume: 44 Page(s): S82 - S83
10/01/2021 Authors: Janopaul-Naylor J; Liu Y; Stokes W
Concomitant Fibrates and Immunotherapy in Non-Small Cell Lung Cancer Patients in the Veterans Health Administration
Volume: 16 Page(s): S1128 - S1129
10/01/2021 Authors: Stokes W; Behera M; Jiang R; Gutman D; Huang Z; Giuste F; Burns A; Sebastian N; Ramalingam S; Sukhatme V
Lung Stereotactic Body Radiation Therapy for Treatment of Oligoprogressive and Oligorecurrent Metastatic Disease: A Multi-Center Analysis
Volume: 16 Page(s): S957 - S958
10/01/2021 Authors: Tian S; Kazzi B; Mccook A; Switchenko J; Stokes W; Shelton J; Kahn S; Carlisle J; Steuer C; Owonikoko T
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016.
Cancer Med Volume: 10 Page(s): 6070 - 6077
09/01/2021 Authors: Taylor MA; Switchenko J; Stokes W; Patel MR; McDonald M; Steuer C; Aiken A; Beitler JJ; Shin DM; Saba NF
Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
Head Neck Volume: 43 Page(s): 2253
07/01/2021 Authors: Pfister NT; Beitler JJ; Stokes WA
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.
Oral Oncol Volume: 117 Page(s): 105294
06/01/2021 Authors: Patel MR; Ottenstein L; Ryan M; Farrell A; Studer M; Baddour HM; Magliocca K; Griffith C; Stokes W; Switchenko J
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
Int J Radiat Oncol Biol Phys Volume: 109 Page(s): 867 - 879
03/15/2021 Authors: Hess CB; Nasti TH; Dhere VR; Kleber TJ; Switchenko JM; Buchwald ZS; Stokes WA; Weinberg BD; Rouphael N; Steinberg JP
Repurposing Statin Drugs to Decrease Toxicity and Improve Survival Outcomes in Head and Neck Cancer.
OTO Open Volume: 5 Page(s): 2473974X211065715
01/01/2021 Authors: Bourguillon RO; Stokes WA; Dorth J; Schmitt NC
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 1401
12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes WA; Nasti T; Switchenko J; Weinberg BD; Rouphael N; Steinberg JP; Godette KD; Murphy DJ
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
Cancer Volume: 126 Page(s): 5109 - 5113
12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma.
Laryngoscope Volume: 130 Page(s): E850 - E857
12/01/2020 Authors: Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS
Impact of Postoperative Radiation Therapy Timing on Survival in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Volume: 108 Page(s): E805 - E805
11/01/2020 Authors: Tian S; Switchenko J; Patel MR; Saba NF; Shin DM; Steuer C; Dhere VR; McDonald MW; Higgins KA; Beitler JJ
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day-7 interim analysis of a registered clinical trial.
Volume: 26
09/01/2020 Authors: Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R
Cone-beam CT-derived relative stopping power map generation via deep learning for proton radiotherapy.
Med Phys Volume: 47 Page(s): 4416 - 4427
09/01/2020 Authors: Harms J; Lei Y; Wang T; McDonald M; Ghavidel B; Stokes W; Curran WJ; Zhou J; Liu T; Yang X
COMPARISON OF THE 7TH AND 8TH EDITIONS OF THE AMERICAN JOINT COMMITTEE ON CANCER (AJCC) STAGING FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS (OPSCC): A SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM (SEER) DATABASE ANALYSIS
Volume: 35 Page(s): S72 - S72
07/01/2020 Authors: Vijayvargiya P; Trivedi S; Song H; Liu Y; Steuer C; Stokes W; Kaka A; Patel M; Chen G; Shin D
Detection and Implications of Occult Contralateral Nodal Spread in Human Papillomavirus-Associated Base of Tongue Cancer.
JAMA Otolaryngol Head Neck Surg Volume: 146 Page(s): 586 - 587
06/01/2020 Authors: Stokes WA; Qian DC; Beitler JJ
Utilization patterns of immune checkpoint inhibitors (ICI) for non-small cell lung cancer (NSCLC) within the veterans health administration (VHA).
Volume: 38
05/20/2020 Authors: Moghanaki D; Jiang R; Gutman D; Burns A; Sukhatme V; Stokes W; Ramalingam SS; Sukhatme V; Behera M
Outcomes and Predictive Value of Post-Adjuvant Therapy Surveillance PET/CECT for Locally Advanced Oral Squamous Cell Carcinoma
Volume: 106 Page(s): 1180 - 1180
04/01/2020 Authors: Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis
Volume: 106 Page(s): 1200 - 1201
04/01/2020 Authors: Vijayvargiya P; Trivedi S; Song H; Liu Y; Steuer C; Stokes WA; Kaka AS; Patel MR; Chen G; Shin DM
Epidemiology and treatment trends for primary tracheal squamous cell carcinoma.
Laryngoscope Volume: 130 Page(s): 405 - 412
02/01/2020 Authors: Hararah MK; Stokes WA; Oweida A; Patil T; Amini A; Goddard J; Bowles DW; Karam SD
Multi-Criteria Hybrid Proton-Photon Inverse Planning for Oropharyngeal Cancer
Volume: 105 Page(s): E424 - E425
09/01/2019 Authors: Lin Y; McDonald MW; Beitler JJ; Stokes WA; Higgins KA; Harms J; Liu T; Gao H
Early mortality of stage IV non-small cell lung cancer in the United States.
Acta Oncol Volume: 58 Page(s): 1095 - 1101
08/01/2019 Authors: Amini A; Verma V; Glaser SM; Shinde A; Sampath S; Stokes WA; Rusthoven CG; Massarelli E; Salgia R; Gaspar LE
Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma.
Head Neck Volume: 41 Page(s): 2299 - 2308
07/01/2019 Authors: Amini A; Stokes WA; Jones BL; Sampath S; Kang RS; Gernon TJ; Maghami EG; Massarelli E; Bradley CJ; Karam SD
Comparison of the seventh and eighth editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis.
Volume: 37
05/20/2019 Authors: Trivedi S; Song H; Liu Y; Steuer CE; Stokes W; Kaka A; Patel M; Chen ZG; Shin DM; Aiken A
Impact of Operability and Minimally Invasive Techniques on Post-Treatment Mortality with SBRT & Surgery in Early Stage NSCLC
Volume: 104 Page(s): 233 - 233
05/01/2019 Authors: Stokes WA; McDonald MW; Higgins KA; Rusthoven CG
Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
J Pediatr Urol Volume: 15 Page(s): 259.e1 - 259.e7
05/01/2019 Authors: Saltzman AF; Stokes W; Walker J; Cost NG
Evolving trends in the management of high-intermediate risk endometrial cancer in the United States.
Gynecol Oncol Volume: 152 Page(s): 522 - 527
03/01/2019 Authors: Zakem SJ; Robin TP; Smith DE; Amini A; Stokes WA; Lefkowits C; Fisher CM
Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.
Oral Oncol Volume: 90 Page(s): 54 - 66
03/01/2019 Authors: Gupta A; Stokes W; Eguchi M; Hararah M; Amini A; Mueller A; Morgan R; Bradley C; Raben D; McDermott J
Short- and Long-term Opioid Use in Patients with Oral and Oropharynx Cancer.
Otolaryngol Head Neck Surg Volume: 160 Page(s): 409 - 419
03/01/2019 Authors: McDermott JD; Eguchi M; Stokes WA; Amini A; Hararah M; Ding D; Valentine A; Bradley CJ; Karam SD
Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
JAMA Otolaryngol Head Neck Surg Volume: 145 Page(s): 53 - 61
01/01/2019 Authors: Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J
Comparing outcomes of concurrent chemotherapy regimens in patients 65 years old or older with locally advanced oropharyngeal carcinoma.
Cancer Volume: 124 Page(s): 4322 - 4331
11/15/2018 Authors: Amini A; Eguchi M; Jones BL; Stokes WA; Gupta A; McDermott JD; Massarelli E; Bradley CJ; Karam SD
Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis.
Am J Clin Oncol Volume: 41 Page(s): 927 - 932
10/01/2018 Authors: Stokes WA; Robin TP; Jackson MW; Amini A; Schefter TE; Lefkowits CC; Fisher CM
Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Oral Oncol Volume: 84 Page(s): 12 - 19
09/01/2018 Authors: Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Reply to C. Cao et al.
J Clin Oncol Volume: 36 Page(s): 2456 - 2457
08/10/2018 Authors: Stokes WA; Rusthoven CG
Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.
Oral Oncol Volume: 83 Page(s): 73 - 80
08/01/2018 Authors: Hararah MK; Stokes WA; Jones BL; Oweida A; Ding D; McDermott J; Goddard J; Karam SD
Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.
Clin Breast Cancer Volume: 18 Page(s): 220 - 228
06/01/2018 Authors: Stokes WA; Amini A; Jackson MW; Plimpton SR; Kounalakis N; Kabos P; Rabinovitch RA; Rusthoven CG; Fisher CM
Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database.
Int J Radiat Oncol Biol Phys Volume: 101 Page(s): 453 - 461
06/01/2018 Authors: Stokes CL; Stokes WA; Kalapurakal JA; Paulino AC; Cost NG; Cost CR; Garrington TP; Greffe BS; Roach JP; Bruny JL
In Reply to Overgaard etal.
Int J Radiat Oncol Biol Phys Volume: 100 Page(s): 805 - 807
03/01/2018 Authors: Stokes WA; Karam SD
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
J Clin Oncol Volume: 36 Page(s): 642 - 651
03/01/2018 Authors: Stokes WA; Bronsert MR; Meguid RA; Blum MG; Jones BL; Koshy M; Sher DJ; Louie AV; Palma DA; Senan S
Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
Brachytherapy Volume: 17 Page(s): 194 - 200
01/01/2018 Authors: Stokes WA; Jones BL; Schefter TE; Fisher CM
Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.
J Neuroimmunol Volume: 313 Page(s): 118 - 122
12/15/2017 Authors: Stokes WA; Binder DC; Jones BL; Oweida AJ; Liu AK; Rusthoven CG; Karam SD
Organ Preservation for Muscle-Invasive Squamous Cell Carcinoma of the Urinary Bladder in the United States
Volume: 99 Page(s): E266 - E266
10/01/2017 Authors: Stokes WA; Kessler ER; Wilson S; Lam ET; Flaig TW; Kavanagh BD; Pugh TJ
Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States.
Oral Oncol Volume: 72 Page(s): 110 - 116
09/01/2017 Authors: Stokes WA; Stumpf PK; Jones BL; Blatchford PJ; Karam SD; Lanning RM; Raben D
Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.
J Transl Med Volume: 15 Page(s): 168
08/02/2017 Authors: Sumner WA; Stokes WA; Oweida A; Berggren KL; McDermott JD; Raben D; Abbott D; Jones B; Gan G; Karam SD
Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
J Pediatr Urol Volume: 13 Page(s): 386.e1 - 386.e7
08/01/2017 Authors: Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Int J Radiat Oncol Biol Phys Volume: 98 Page(s): 1014 - 1021
08/01/2017 Authors: Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
Head Neck Volume: 39 Page(s): 1113 - 1121
06/01/2017 Authors: Stokes WA; Amini A; Jones BL; McDermott JD; Raben D; Ghosh D; Goddard JA; Bowles DW; Karam SD
A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
Cancer Volume: 123 Page(s): 600 - 608
02/15/2017 Authors: Stokes WA; Jones BL; Bhatia S; Oweida AJ; Bowles DW; Raben D; Goddard JA; McDermott JD; Karam SD
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis.
Pract Radiat Oncol Volume: 7 Page(s): 270 - 278
01/01/2017 Authors: Stokes WA; Kavanagh BD; Raben D; Pugh TJ
Cancer screening rates in individuals with different life expectancies.
JAMA Intern Med Volume: 174 Page(s): 1558 - 1565
10/01/2014 Authors: Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.
J Natl Cancer Inst Volume: 106
07/01/2014 Authors: Chen RC; Chang P; Vetter RJ; Lukka H; Stokes WA; Sanda MG; Watkins-Bruner D; Reeve BB; Sandler HM
Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.
Cancer Volume: 119 Page(s): 2486 - 2493
07/01/2013 Authors: Stokes WA; Hendrix LH; Royce TJ; Allen IM; Godley PA; Wang AZ; Chen RC
Evaluating the plan quality of a general head-and-neck knowledge-based planning model versus separate unilateral/bilateral models.
Med Dosim Volume: 48 Page(s): 44 - 50
Authors: Luca K; Roper J; Wolf J; Kayode O; Bradley J; Stokes WA; Zhang J

Directory section navigation

Profile